𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reboxetine utilization as add-on therapy to SSRI in treatment-resistant depression

✍ Scribed by G. Tavormina; S. Corea; A. Citron


Book ID
119575898
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
122 KB
Volume
12
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy and safety evaluation of lorecl
✍ T Rentmeester; J Hulsman πŸ“‚ Article πŸ“… 1991 πŸ› Elsevier Science 🌐 English βš– 381 KB

Thirteen drug-resistant epilepsy patients received loreclezole as add-on therapy. The trial lasted 6 months. Loreclezole was dosed to reach a target plasma concentration between 1 and 3 mg/l. The seizure frequency in the total group decreased by 23%. A reduction of 50% or more was observed in four p